Probiotics: how microorganisms compete

G Reid

Comment

G Reid. JAMA. 1996.

. 1996 Jul 3;276(1):29-30.

G Reid

No abstract available

Comment on

Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections.
Elmer GW, Surawicz CM, McFarland LV. Elmer GW, et al. JAMA. 1996 Mar 20;275(11):870-6. doi: 10.1001/jama.275.11.870. JAMA. 1996. PMID: 8596226 Review.

Probiotics for oral health: myth or reality?
Bonifait L, Chandad F, Grenier D. Bonifait L, et al. J Can Dent Assoc. 2009 Oct;75(8):585-90. J Can Dent Assoc. 2009. PMID: 19840501 Review.
[A comparative study of the biological properties of Biosporin and other commercial Bacillus-based preparations].
Sorokulova IB. Sorokulova IB. Mikrobiol Z. 1997 Nov-Dec;59(6):43-9. Mikrobiol Z. 1997. PMID: 9511375 Russian.
Lack of correlation between in vitro antibiosis and in vivo protection against enteropathogenic bacteria by probiotic lactobacilli.
Bujalance C, Jiménez-Valera M, Moreno E, Ruiz-López MD, Lasserrot A, Ruiz-Bravo A. Bujalance C, et al. Res Microbiol. 2014 Jan;165(1):14-20. doi: 10.1016/j.resmic.2013.10.006. Epub 2013 Oct 17. Res Microbiol. 2014. PMID: 24140789
[The antagonistic activity of the eubiotic Maxilin towards wound infection and its effect on the antibiotic resistance of microorganisms].
Pichkhadze GM, Rusanov VP, Novoselov VE. Pichkhadze GM, et al. Stomatologiia (Mosk). 2000;79(4):22-7. Stomatologiia (Mosk). 2000. PMID: 10961107 Russian.
[Microbial antagonism and rationale for the use of probiotics in combined therapy of Helicobacter pylori-related diseases].
Tsimmerman IaS, Subbotina LV, Neschisliaev VA. Tsimmerman IaS, et al. Klin Med (Mosk). 2010;88(4):35-42. Klin Med (Mosk). 2010. PMID: 20919568 Review. Russian.